CIAO2B
gene geneOn this page
Also known as CGI-128MIP18CIA2B
Summary
CIAO2B (cytosolic iron-sulfur assembly component 2B, HGNC:24261) is a protein-coding gene on chromosome 16q22.1, encoding Cytosolic iron-sulfur assembly component 2B (Q9Y3D0). Component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins. It is a common-essential gene (DepMap: required in 97.4% of cancer cell lines).
Involved in chromosome segregation and protein maturation. Located in cytosol; nucleoplasm; and spindle. Part of MMXD complex and cytosolic [4Fe-4S] assembly targeting complex.
Source: NCBI Gene 51647 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 35 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 97.4% of screened cell lines (common-essential)
- MANE Select transcript:
NM_016062
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24261 |
| Approved symbol | CIAO2B |
| Name | cytosolic iron-sulfur assembly component 2B |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-128, MIP18, CIA2B |
| Ensembl gene | ENSG00000166595 |
| Ensembl biotype | protein_coding |
| OMIM | 614778 |
| Entrez | 51647 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000422424, ENST00000562362, ENST00000563490, ENST00000567511, ENST00000568572, ENST00000569299
RefSeq mRNA: 1 — MANE Select: NM_016062
NM_016062
CCDS: CCDS45506
Canonical transcript exons
ENST00000422424 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001621441 | 66933987 | 66934066 |
| ENSE00001665391 | 66932065 | 66932300 |
| ENSE00001687555 | 66934223 | 66934402 |
| ENSE00003479677 | 66932780 | 66932825 |
| ENSE00003647556 | 66933614 | 66933739 |
Expression profiles
Bgee: expression breadth ubiquitous, 285 present calls, max score 99.07.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 83.4264 / max 229.1838, expressed in 1827 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157733 | 80.7492 | 1826 |
| 157734 | 1.9012 | 1341 |
| 157732 | 0.7761 | 390 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 99.07 | gold quality |
| gastrocnemius | UBERON:0001388 | 98.77 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.63 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 98.58 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.42 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 98.36 | gold quality |
| spinal cord | UBERON:0002240 | 98.29 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 98.25 | gold quality |
| muscle of leg | UBERON:0001383 | 98.18 | gold quality |
| heart left ventricle | UBERON:0002084 | 98.15 | gold quality |
| apex of heart | UBERON:0002098 | 98.13 | gold quality |
| cardiac ventricle | UBERON:0002082 | 98.10 | gold quality |
| pituitary gland | UBERON:0000007 | 98.06 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 98.06 | gold quality |
| left adrenal gland | UBERON:0001234 | 98.02 | gold quality |
| right atrium auricular region | UBERON:0006631 | 98.00 | gold quality |
| right adrenal gland | UBERON:0001233 | 97.94 | gold quality |
| esophagus mucosa | UBERON:0002469 | 97.90 | gold quality |
| prefrontal cortex | UBERON:0000451 | 97.89 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.87 | gold quality |
| amygdala | UBERON:0001876 | 97.86 | gold quality |
| oocyte | CL:0000023 | 97.85 | gold quality |
| muscle organ | UBERON:0001630 | 97.85 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.84 | gold quality |
| cingulate cortex | UBERON:0003027 | 97.84 | gold quality |
| adrenal cortex | UBERON:0001235 | 97.83 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 97.83 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 97.75 | gold quality |
| left coronary artery | UBERON:0001626 | 97.73 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 14.42 |
| E-MTAB-8142 | yes | 10.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting CIAO2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-556-3P | 99.74 | 68.75 | 1203 |
| HSA-MIR-4427 | 99.34 | 70.33 | 1854 |
| HSA-MIR-520E-5P | 99.27 | 68.90 | 1513 |
| HSA-MIR-10399-5P | 99.17 | 69.87 | 2610 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-4289 | 98.26 | 66.90 | 810 |
| HSA-MIR-4471 | 95.11 | 66.84 | 755 |
| HSA-MIR-8059 | 95.11 | 66.30 | 646 |
| HSA-MIR-4765 | 93.11 | 66.17 | 737 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 97.4% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 9)
- these findings suggest that FAM96B acts as a regulator of E2-2 through the control of its protein expression. (PMID:21722264)
- The mammalian proteins MMS19, MIP18, and ANT2 are involved in cytoplasmic iron-sulfur cluster protein assembly. (PMID:23150669)
- CIA2B-CIA1-MMS19 and CIA2A-CIA1 assist different branches of Fe/S protein assembly and intimately link this process to cellular iron regulation via IRP1 Fe/S cluster maturation and IRP2 stabilization. (PMID:23891004)
- Co-localization experiments by fluorescent confocal microscopy revealed that FAM96B colocalized with prelamin A in HEK-293 cells. (PMID:24041693)
- Data suggest that CIA2B and MMS19 physically interact with C-terminus of viperin/RSAD2; CIAO1 appears to function as primary viperin-interacting protein; CIA2A binds to N-terminus of viperin in CIAO1-, CIA2B-, and MMS19-independent fashion. (CIA2B = metallochaperone CIA2B/FAM96B; MMS19 = transcription factor MMS19; CIAO1 = cytosolic iron-sulfur assembly component 1; CIA2A = metallochaperone CIA2A/Fam96a) (PMID:28615450)
- We performed a yeast two-hybrid screen on a human fetal brain cDNA library and identified FAM96B as a novel binding partner of SelW. FRET analyses confirmed the interaction between SelW’ and FAM96B. (PMID:30876693)
- FAM96B inhibits the senescence of dental pulp stem cells. (PMID:32039527)
- Structural insights into Fe-S protein biogenesis by the CIA targeting complex. (PMID:32632277)
- Fam96b recruits brain-type creatine kinase to fuel mitotic spindle formation. (PMID:36503010)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ciao2b | ENSDARG00000052010 |
| mus_musculus | Ciao2b | ENSMUSG00000031879 |
| rattus_norvegicus | Ciao2b | ENSRNOG00000011865 |
| drosophila_melanogaster | galla-2 | FBGN0036107 |
| caenorhabditis_elegans | WBGENE00009736 |
Paralogs (1): CIAO2A (ENSG00000166797)
Protein
Protein identifiers
Cytosolic iron-sulfur assembly component 2B — Q9Y3D0 (reviewed: Q9Y3D0)
Alternative names: MSS19-interacting protein of 18 kDa, Mitotic spindle-associated MMXD complex subunit MIP18, Protein FAM96B
All UniProt accessions (4): Q9Y3D0, H3BNV7, J3KS95, J3QLT9
UniProt curated annotations — full annotation on UniProt →
Function. Component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins. As a CIA complex component and in collaboration with CIAO1 and MMS19, binds to and facilitates the assembly of most cytosolic-nuclear Fe/S proteins. As part of the mitotic spindle-associated MMXD complex it plays a role in chromosome segregation, probably by facilitating iron-sulfur cluster assembly into ERCC2/XPD. Together with MMS19, facilitates the transfer of Fe-S clusters to the motor protein KIF4A, which ensures proper localization of KIF4A to mitotic machinery components to promote the progression of mitosis.
Subunit / interactions. Component of the CIA complex. Component of the MMXD complex, which includes CIAO1, ERCC2, CIAO2B, MMS19 and SLC25A5. Interacts with CIAO1, ERCC2 and MMS19; the interactions are direct. Interacts with KIF4A; the interaction facilitates the transfer of Fe-S clusters to KIF4A to ensure proper localization of KIF4A to the mitotic machinery. Interacts with CCDC117; the interaction is direct.
Subcellular location. Nucleus. Cytoplasm. Cytoskeleton. Spindle. Midbody.
Similarity. Belongs to the MIP18 family.
RefSeq proteins (1): NP_057146* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002744 | MIP18-like | Domain |
| IPR034904 | FSCA_dom_sf | Homologous_superfamily |
| IPR039796 | MIP18 | Family |
Pfam: PF01883
UniProt features (2 total): initiator methionine 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y3D0-F1 | 85.56 | 0.49 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-2564830 | Cytosolic iron-sulfur cluster assembly |
MSigDB gene sets: 99 (showing top):
chr16q22, GOBP_PROTEIN_MATURATION, IRF1_Q6, ELK1_01, MCCLUNG_COCAIN_REWARD_4WK, GOCC_SPINDLE, GOCC_MIDBODY, GOBP_CELL_CYCLE_PROCESS, SCGGAAGY_ELK1_02, MULLIGHAN_MLL_SIGNATURE_1_UP, MGGAAGTG_GABP_B, IRITANI_MAD1_TARGETS_UP, GOBP_CHROMOSOME_SEGREGATION, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17, FORTSCHEGGER_PHF8_TARGETS_DN
GO Biological Process (2): chromosome segregation (GO:0007059), protein maturation (GO:0051604)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (9): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), spindle (GO:0005819), cytosol (GO:0005829), midbody (GO:0030496), MMXD complex (GO:0071817), cytosolic [4Fe-4S] assembly targeting complex (GO:0097361), cytoskeleton (GO:0005856)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| intracellular membraneless organelle | 2 |
| cell cycle process | 1 |
| gene expression | 1 |
| protein metabolic process | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| microtubule cytoskeleton | 1 |
| cytoplasm | 1 |
| spindle | 1 |
| protein-containing complex | 1 |
| intracellular protein-containing complex | 1 |
| iron-sulfur cluster assembly complex | 1 |
Protein interactions and networks
STRING
1232 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CIAO2B | CIAO1 | O76071 | 998 |
| CIAO2B | MMS19 | Q96T76 | 997 |
| CIAO2B | SLC25A5 | P05141 | 947 |
| CIAO2B | SLC25A6 | P12236 | 945 |
| CIAO2B | CIAO3 | Q9H6Q4 | 878 |
| CIAO2B | NUBP1 | P53384 | 815 |
| CIAO2B | CIAPIN1 | Q6FI81 | 718 |
| CIAO2B | ERCC2 | P18074 | 665 |
| CIAO2B | RTEL1 | Q9NZ71 | 655 |
| CIAO2B | BRIP1 | Q9BX63 | 647 |
| CIAO2B | NDOR1 | Q9UHB4 | 642 |
| CIAO2B | DNA2 | P51530 | 622 |
| CIAO2B | ABCB7 | O75027 | 556 |
| CIAO2B | GLRX3 | O76003 | 527 |
| CIAO2B | NFS1 | Q9Y697 | 519 |
IntAct
151 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CIAO2B | CIAO1 | psi-mi:“MI:0915”(physical association) | 0.950 |
| CIAO1 | CIAO2B | psi-mi:“MI:0915”(physical association) | 0.950 |
| CIAO2B | CIAO1 | psi-mi:“MI:0914”(association) | 0.950 |
| CIAO2B | CIAO1 | psi-mi:“MI:0407”(direct interaction) | 0.950 |
| MMS19 | CIAO1 | psi-mi:“MI:0914”(association) | 0.910 |
| MMS19 | CIAO1 | psi-mi:“MI:0915”(physical association) | 0.910 |
| MMS19 | CIAO2B | psi-mi:“MI:0915”(physical association) | 0.830 |
| CIAO2B | MMS19 | psi-mi:“MI:0915”(physical association) | 0.830 |
| MMS19 | CIAO2B | psi-mi:“MI:0407”(direct interaction) | 0.830 |
| MMS19 | ERCC2 | psi-mi:“MI:0915”(physical association) | 0.690 |
BioGRID (175): FAM96B (Two-hybrid), FAM96B (Affinity Capture-MS), FAM96B (Affinity Capture-Western), FAM96B (Affinity Capture-Western), FAM96B (Affinity Capture-MS), FAM96B (Two-hybrid), FAM96B (Co-fractionation), CIAO1 (Two-hybrid), FAM96B (Affinity Capture-MS), FAM96B (Affinity Capture-MS), FAM96B (Affinity Capture-MS), FAM96B (Two-hybrid), FAM96B (Affinity Capture-MS), FAM96B (Affinity Capture-MS), FAM96B (Two-hybrid)
ESM2 similar proteins: A0A096MJN4, A8MR89, B3MRT7, B3NYF7, B4H303, B4IMF6, B4JWR9, B4M375, B4NE93, B4PZ52, B4R3T1, B5DKJ8, O01479, O13718, O43236, O62252, P08761, P15807, P16393, P23337, P28661, P32783, P32860, P38829, P40487, P46580, P53893, Q3T0U7, Q54QK1, Q5R6R7, Q6BYP7, Q6CKE9, Q6CLC9, Q6CPN1, Q6FMP0, Q6FTG1, Q75AZ9, Q8RXN5, Q8SY96, Q92599
Diamond homologs: A8MR89, O62252, P38829, Q3T0U7, Q54QK1, Q9C9G6, Q9D187, Q9DCL2, Q9GPR0, Q9H5X1, Q9SR25, Q9UTL0, Q9V968, Q9VTC4, Q9Y3D0
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CIAO2B | “form complex” | “CIAO2B cytosolic iron-sulfur protein assembly complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 84 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Cytosolic iron-sulfur cluster assembly | 5 | 74.6× | 1e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
427 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:66932299:CA:C | acceptor_gain | 0.9900 |
| 16:66932301:C:CC | acceptor_gain | 0.9900 |
| 16:66933609:CTGA:C | donor_loss | 0.9900 |
| 16:66933610:TGAC:T | donor_loss | 0.9900 |
| 16:66933611:GAC:G | donor_loss | 0.9900 |
| 16:66933612:A:T | donor_loss | 0.9900 |
| 16:66933613:C:CA | donor_loss | 0.9900 |
| 16:66933646:TG:T | donor_gain | 0.9900 |
| 16:66933737:AACC:A | acceptor_loss | 0.9900 |
| 16:66933739:CCTGG:C | acceptor_loss | 0.9900 |
| 16:66933740:C:CG | acceptor_loss | 0.9900 |
| 16:66933746:G:C | acceptor_gain | 0.9900 |
| 16:66932299:CACT:C | acceptor_loss | 0.9800 |
| 16:66932300:ACTAG:A | acceptor_loss | 0.9800 |
| 16:66932301:C:A | acceptor_loss | 0.9800 |
| 16:66932317:G:C | acceptor_gain | 0.9800 |
| 16:66932779:CCTG:C | donor_gain | 0.9800 |
| 16:66932825:TC:T | acceptor_loss | 0.9800 |
| 16:66932826:C:CC | acceptor_gain | 0.9800 |
| 16:66932827:T:G | acceptor_loss | 0.9800 |
| 16:66933744:T:C | acceptor_gain | 0.9800 |
| 16:66933744:T:TC | acceptor_gain | 0.9800 |
| 16:66934264:T:TA | donor_gain | 0.9800 |
| 16:66934267:T:TA | donor_gain | 0.9800 |
| 16:66932297:TTCA:T | acceptor_gain | 0.9700 |
| 16:66932298:TCA:T | acceptor_gain | 0.9700 |
| 16:66932299:CAC:C | acceptor_gain | 0.9700 |
| 16:66932317:G:GC | acceptor_gain | 0.9700 |
| 16:66932774:ACTT:A | donor_loss | 0.9700 |
| 16:66932776:TTACC:T | donor_loss | 0.9700 |
AlphaMissense
1057 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:66932261:G:T | A145D | 1.000 |
| 16:66932264:G:T | A144D | 1.000 |
| 16:66932268:C:G | A143P | 1.000 |
| 16:66932273:C:G | R141P | 1.000 |
| 16:66932276:T:A | E140V | 1.000 |
| 16:66932277:C:T | E140K | 1.000 |
| 16:66932278:C:A | K139N | 1.000 |
| 16:66932278:C:G | K139N | 1.000 |
| 16:66932281:A:C | D138E | 1.000 |
| 16:66932281:A:T | D138E | 1.000 |
| 16:66932282:T:A | D138V | 1.000 |
| 16:66932283:C:G | D138H | 1.000 |
| 16:66932288:A:G | L136P | 1.000 |
| 16:66932288:A:T | L136H | 1.000 |
| 16:66933642:A:G | L107P | 1.000 |
| 16:66933660:A:G | L101P | 1.000 |
| 16:66933663:C:A | G100V | 1.000 |
| 16:66933663:C:T | G100D | 1.000 |
| 16:66933664:C:G | G100R | 1.000 |
| 16:66933666:A:T | I99N | 1.000 |
| 16:66933683:G:C | C93W | 1.000 |
| 16:66933684:C:A | C93F | 1.000 |
| 16:66933684:C:T | C93Y | 1.000 |
| 16:66933685:A:G | C93R | 1.000 |
| 16:66933699:G:T | P88Q | 1.000 |
| 16:66933700:G:A | P88S | 1.000 |
| 16:66933705:A:G | F86S | 1.000 |
| 16:66934015:A:G | L65S | 1.000 |
| 16:66934024:A:T | L62Q | 1.000 |
| 16:66934035:A:C | H58Q | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000406021 (16:66935881 C>CTCCTAGAA), RS1000967376 (16:66933369 A>C), RS1002764377 (16:66932782 G>A,C), RS1002905238 (16:66934168 T>C), RS1003225189 (16:66932478 C>T), RS1003292966 (16:66935607 G>A,C,T), RS1005153402 (16:66934966 C>T), RS1005358757 (16:66932004 TC>T,TCC,TCCC), RS1006456135 (16:66931734 T>A), RS1006618489 (16:66932327 G>A,C,T), RS1006669721 (16:66932069 T>C), RS1007251442 (16:66933345 G>C), RS1007609862 (16:66933078 C>T), RS1008958168 (16:66933928 G>A), RS1011410420 (16:66932446 A>C)
Disease associations
OMIM: gene MIM:614778 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4295989 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs11075646 | CES2, CIAO2B | 0.00 | 0 |
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| sodium arsenite | increases expression, increases abundance | 2 |
| Rotenone | decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenate | decreases expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| cobaltous chloride | decreases expression | 1 |
| pyrimidifen | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Vitamin E | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4118721 | Binding | Binding affinity to FAM96B in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay | Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. — Bioorg Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.